Top Markets
Coin of the day
Talaris Therapeutics, Inc. Talaris Therapeutics, Inc.

Talaris Therapeutics, Inc.

TALS
주식 순위 #21258
Talaris Therapeutics, Inc. is a cell therapy company operating in the United... Talaris Therapeutics, Inc. is a cell therapy company operating in the United States, currently in its late clinical development stages. Its mission involves pioneering an allogeneic hematopoietic stem cell transplantation strategy designed to revolutionize treatment paradigms for solid organ transplantation, severe autoimmune conditions, and significant non-malignant blood, immune, and metabolic disorders. The company's flagship product, FCR001, is an innovative allogeneic cell therapy presently in Phase II clinical trials for patients undergoing living donor kidney transplantation. Beyond this, Talaris Therapeutics is actively advancing FCR002 for use in deceased donor kidney transplants, investigating FCR001 for individuals with a severe form of scleroderma, and exploring its applicability for a range of other serious non-malignant blood, immune, or metabolic conditions. Founded in 1988, the company maintains its headquarters in Louisville, Kentucky.
주가
$2.72
마지막 동기화: 2023-10-19
시가총액
$111.47M
변동 (1일)
-0.73%
변동 (1년)
0.00%
국가
US
거래 Talaris Therapeutics, Inc. (TALS)

카테고리

Talaris Therapeutics, Inc. (TALS)의 주식 분할 이력
Talaris Therapeutics, Inc. 주식 (심볼: TALS)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 23, 2026에 발생했습니다.
Aug 23, 2026 이전에 매수한 TALS 주식 1주는 현재 0주의 TALS 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH